MAXITROL Drug Patent Profile
✉ Email this page to a colleague
When do Maxitrol patents expire, and when can generic versions of Maxitrol launch?
Maxitrol is a drug marketed by Sandoz and Harrow Eye and is included in three NDAs.
The generic ingredient in MAXITROL is dexamethasone; neomycin sulfate; polymyxin b sulfate. There are thirty-nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dexamethasone; neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MAXITROL?
- What are the global sales for MAXITROL?
- What is Average Wholesale Price for MAXITROL?
Summary for MAXITROL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Clinical Trials: | 3 |
| Drug Prices: | Drug price information for MAXITROL |
| What excipients (inactive ingredients) are in MAXITROL? | MAXITROL excipients list |
| DailyMed Link: | MAXITROL at DailyMed |
Recent Clinical Trials for MAXITROL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Brandon Eye Associates, PA | Phase 4 |
| Universiti Sains Malaysia | N/A |
| University of Science Malaysia | N/A |
Pharmacology for MAXITROL
| Drug Class | Aminoglycoside Antibacterial Corticosteroid Polymyxin-class Antibacterial |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for MAXITROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | MAXITROL | dexamethasone; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 050065-002 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Harrow Eye | MAXITROL | dexamethasone; neomycin sulfate; polymyxin b sulfate | SUSPENSION/DROPS;OPHTHALMIC | 050023-002 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | MAXITROL | dexamethasone; neomycin sulfate; polymyxin b sulfate | SUSPENSION/DROPS;OPHTHALMIC | 062341-001 | May 22, 1984 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
